Vanessa Kennedy

Assistant Professor @StanfordMed | Myeloid Malignancies, Cellular Therapies

[OncoDaily @oncodaily]

Excellent article with an overview of the first years of JCO Clinical Cancer Informatics - @ADesaiMD
@ASCO @ONealCancerUAB @JCOCCI_ASCO @vekennedy @Ben_A_Bates @MichaelRooney67
https://t.co/UGbqo6KiEH

#ASCO #Cancer #OncoDaily #Oncology

[Transplantation and Cellular Therapy Journal @ASTCT_Journal]

A 10-year study examining #cGVHD durability and immune reconstitution reveals sustained reduction in cGVHD rate and lasting B cell changes post #HCT Rituximab prophylaxis, with altered subset composition and decreased alloantibody formation. @vekennedy https://t.co/Q3FRz2cWEB

[Haifaa Abdulhaq @AbdulhaqHaifaa]

Thank you to all our speakers and participants in making @btfoundation hematology and breast conference in Fresno a great success. @hemedoc @AlfredChung11 @vekennedy @Mohamed Bukari @ Matthew Frank@JoeToscano
#UCSFFresno

[Atul Butte @atulbutte]

Thrilled to announce our new @NEJM_AI article (https://t.co/LLgb1eVRKp)!
Lead author @madhumitasushil worked with @TravisZack2 @vekennedy @divneetM @bmeow19 all in @UCSF_BCHSI @UCSFCancer.
To computationally understand where patients are in their care journey, we have to understand their clinical notes. This work shows how @OpenAI GPT-4 with @Azure enables a next-generation level of auto-curation from progress notes, including cancer.

A thread 🧵…

[UChicago Leukemia Program @UChicagoLeuk]

We are excited to host and learn from Dr Vanessa Kennedy today at @UCCancerCenter Leukemia Research Seminar. @vekennedy @UCSFCancer

[Anand Patel @Anand_88_Patel]

Please join us on June 2nd at 1pm for the @ASCO #ASCO23 oral abstract session on leukemia, MDS & cell therapies! It's an incredible lineup of abstracts covering CAR-T, myeloid malignancies, and ALL!

I'm excited to be discussing Abstracts 7003-7005 #leusm #mdssm

[Ben Hamner @benhamner]

Hiring core of ml/data/engineering team for our new co (w/ @antgoldbloom). DM if interested

Goal: Apply AI to build high quality data repo of world's knowledge. Make this repo delightful to consume through APIs, UIs, DB integrations & intelligent joins to your internal data

[Kelly Schoenbeck @KellySchoenbeck]

Congratulations to ⁦@UCSFCancer⁩ super 🌟⁦@vekennedy⁩ on her amazing oral presentation at #ASH22 on single cell sequencing of FLT3 mutated AML treated w/ Gilt/ven. Fantastic work! ⁦@SmithLabSF⁩ @ASH_hematology⁩ ⁦

[Jerry Lee, MD, MPhil, MS @TheBloodDoc]

UCSF, the most photogenic crew!! @vekennedy @KelseyNatsuhara @mattfjones1 @corynnkasap @thehemeoncfellow and in absentia @RahulBanerjeeMD @UCSFCancer @HemoncUcsf @UCSFHospitals @UCSF #ASH22 🤣🥳😎

[Vanessa Kennedy @vekennedy]

@RahulBanerjeeMD @anobelodisho I love this so much.

[Anand Patel @Anand_88_Patel]

A very helpful paper in @BloodAdvances by @vekennedy et al outlining outcomes in mast cell leukemia #mpnsm #leusm
- median OS 1.6 years
- midostaurin the most commonly used agent
- mutational profile in below image
https://t.co/GumnkfdiaV

[ANCO @ANCO_News]

@vekennedy recipient of an ANCO sponsored ASCO YIA updating ANCO’s Board of Director’s on her project.

[JCO Clinical Cancer Informatics @JCOCCI_ASCO]

🎉👋 Welcome to our new #JCOCCI Editorial Fellows! @Ben_A_Bates & @vekennedy will spend the next year getting a peek behind the curtain of JCO CCI, and learning from @SanjayAnejaMD and others what it's like to be a journal editor.

[Vanessa Kennedy @vekennedy]

@jbullockruns I use a non-audio alert (vibration on my Apple Watch)— wakes me up, partner (and baby!) both stay asleep

[Frontiers - Oncology @FrontOncology]

⭐ #2: FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies

👨‍⚕️👩‍⚕️ @vekennedy & Catherine C. Smith

Read here 👉 https://t.co/lFnfKY64QB

@UCSFCancer #AMLsm #LEUsm #Leukemia #HemOnc #Oncology #OpenAccess

[Vanessa Kennedy @vekennedy]

@s_brond Sam’s scaffolds are the best 😊

[Vanessa Kennedy @vekennedy]

@RahulBanerjeeMD @hemedoc @UCSFCancer @SwethaKMD @MazieTsangMD @corynnkasap @KellySchoenbeck This session (and the earlier one on aGVHD) was so so helpful!

[Bita Fakhri @bitafakhri]

A fantastic write-up of a case of EBV-negative Aggressive NK-cell Leukemia (ANKL) and how genomics helped clarify the diagnosis by ⁦@UCSFCancer⁩ star fellow ⁦@vekennedy. ⁦@drruizcor⁩ ⁦@BobOhgami⁩ ⁦@ncdunavin⁩ https://t.co/Ypo6URxs3e

[Vanessa Kennedy @vekennedy]

@VPrasadMDMPH Thank you for writing this! I've also been captivated by Ikigai (both in medical and non-medical life) for quite a while, and it was great to read your thoughts.

[Vanessa Kennedy @vekennedy]

@RahulBanerjeeMD @hemedoc Your super power is coming up with fantastic trial names!